SOCS3 may indeed be a therapeutic target in a number of neurologic diseases, however, strategies to selectively inhibit SOCS3 in neurons and oligodendrocytes, or induce SOCS3 in microglia and astrocytes, will need to be explored. The gene discussed is SOCS3; the disease is nervous system disorder.